Key result
Perioperative management of oral anticoagulation depends on procedural bleeding risk and patient thromboembolic risk, with bridging therapy recommended only for high-risk patients on coumarin derivatives.
Why the study?
About 10% of patients on chronic oral anticoagulant therapy require an invasive procedure that carries an increased risk of perioperative bleeding, requiring careful balancing against thromboembolic risk.
How should chronic oral anticoagulant therapy be managed perioperatively in patients requiring an invasive procedure?
How should chronic oral anticoagulant therapy be managed perioperatively in patients requiring an invasive procedure?
Perioperative management of oral anticoagulants requires balancing thromboembolic and bleeding risks, with bridging therapy generally avoided for NOACs and low-risk coumarin patients.
No takes yet. Share an insight, caveat, or question.
May inform risk-stratified bridging decisions; leaves open prospective validation in contemporary cohorts.
Wagner et al. (2019) conducted a review in Patients taking chronic oral anticoagulant therapy requiring an invasive procedure. Perioperative management of anticoagulant therapy was evaluated. Perioperative management of oral anticoagulation depends on procedural bleeding risk and patient thromboembolic risk, with bridging therapy recommended only for high-risk patients on coumarin derivatives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: